BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 27633575)

  • 1. Epigenetic regulation of peroxiredoxins: Implications in the pathogenesis of cancer.
    Ow SH; Chua PJ; Bay BH
    Exp Biol Med (Maywood); 2017 Jan; 242(2):140-147. PubMed ID: 27633575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variable overoxidation of peroxiredoxins in human lung cells in severe oxidative stress.
    Lehtonen ST; Markkanen PM; Peltoniemi M; Kang SW; Kinnula VL
    Am J Physiol Lung Cell Mol Physiol; 2005 May; 288(5):L997-1001. PubMed ID: 15626747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial peroxiredoxin involvement in antioxidant defence and redox signalling.
    Cox AG; Winterbourn CC; Hampton MB
    Biochem J; 2009 Dec; 425(2):313-25. PubMed ID: 20025614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma.
    Kinnula VL; Lehtonen S; Sormunen R; Kaarteenaho-Wiik R; Kang SW; Rhee SG; Soini Y
    J Pathol; 2002 Mar; 196(3):316-23. PubMed ID: 11857495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs and Epigenetics.
    Moutinho C; Esteller M
    Adv Cancer Res; 2017; 135():189-220. PubMed ID: 28882223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new insight on reciprocal relationship between microRNA expression and epigenetic modifications in human lung cancer.
    Sheervalilou R; Shirvaliloo S; Fekri Aval S; Khamaneh AM; Sharifi A; Ansarin K; Zarghami N
    Tumour Biol; 2017 May; 39(5):1010428317695032. PubMed ID: 28468581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total peroxiredoxin expression is associated with survival in patients with follicular lymphoma.
    Peroja P; Haapasaari KM; Mannisto S; Miinalainen I; Koivunen P; Leppä S; Karjalainen-Lindsberg ML; Kuusisto ME; Turpeenniemi-Hujanen T; Kuittinen O; Karihtala P
    Virchows Arch; 2016 May; 468(5):623-30. PubMed ID: 26983700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRDX4 and Its Roles in Various Cancers.
    Jia W; Chen P; Cheng Y
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819864313. PubMed ID: 31311441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of peroxiredoxin decreasing oxidative stress in hypertensive aortic smooth muscle.
    Lee CK; Kim HJ; Lee YR; So HH; Park HJ; Won KJ; Park T; Lee KY; Lee HM; Kim B
    Biochim Biophys Acta; 2007 Jul; 1774(7):848-55. PubMed ID: 17556052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetics, the holy grail in the pathogenesis of systemic sclerosis.
    Altorok N; Almeshal N; Wang Y; Kahaleh B
    Rheumatology (Oxford); 2015 Oct; 54(10):1759-70. PubMed ID: 24740406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation, histone acetylation and methylation of epigenetic modifications as a therapeutic approach for cancers.
    Yen CY; Huang HW; Shu CW; Hou MF; Yuan SS; Wang HR; Chang YT; Farooqi AA; Tang JY; Chang HW
    Cancer Lett; 2016 Apr; 373(2):185-92. PubMed ID: 26808576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetics and miRNAs in human cancer.
    Fabbri M; Calin GA
    Adv Genet; 2010; 70():87-99. PubMed ID: 20920746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetics in Parkinson's Disease.
    Pavlou MAS; Outeiro TF
    Adv Exp Med Biol; 2017; 978():363-390. PubMed ID: 28523556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylomes, histone codes and miRNAs: tying it all together.
    Guil S; Esteller M
    Int J Biochem Cell Biol; 2009 Jan; 41(1):87-95. PubMed ID: 18834952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple functions of peroxiredoxins: peroxidases, sensors and regulators of the intracellular messenger H₂O₂, and protein chaperones.
    Rhee SG; Woo HA
    Antioxid Redox Signal; 2011 Aug; 15(3):781-94. PubMed ID: 20919930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxiredoxin Involvement in the Initiation and Progression of Human Cancer.
    Hampton MB; Vick KA; Skoko JJ; Neumann CA
    Antioxid Redox Signal; 2018 Mar; 28(7):591-608. PubMed ID: 29237274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship Between Noncoding RNA Dysregulation and Epigenetic Mechanisms in Cancer.
    Suzuki H; Maruyama R; Yamamoto E; Niinuma T; Kai M
    Adv Exp Med Biol; 2016; 927():109-35. PubMed ID: 27376733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic regulation of active Chinese herbal components for cancer prevention and treatment: A follow-up review.
    Huang Z; Huang Q; Ji L; Wang Y; Qi X; Liu L; Liu Z; Lu L
    Pharmacol Res; 2016 Dec; 114():1-12. PubMed ID: 27697644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic Gene Regulation by Dietary Compounds in Cancer Prevention.
    Montgomery M; Srinivasan A
    Adv Nutr; 2019 Nov; 10(6):1012-1028. PubMed ID: 31100104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone Deacetylases and Their Regulatory MicroRNAs in Hepatocarcinogenesis.
    Kim HS; Shen Q; Nam SW
    J Korean Med Sci; 2015 Oct; 30(10):1375-80. PubMed ID: 26425032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.